373 related articles for article (PubMed ID: 9745446)
1. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant.
Chaidarun SS; Swearingen B; Alexander JM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3308-15. PubMed ID: 9745446
[TBL] [Abstract][Full Text] [Related]
2. A tumor-specific truncated estrogen receptor splice variant enhances estrogen-stimulated gene expression.
Chaidarun SS; Alexander JM
Mol Endocrinol; 1998 Sep; 12(9):1355-66. PubMed ID: 9731704
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas.
Chaidarun SS; Klibanski A; Alexander JM
J Clin Endocrinol Metab; 1997 Apr; 82(4):1058-65. PubMed ID: 9100573
[TBL] [Abstract][Full Text] [Related]
4. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
[TBL] [Abstract][Full Text] [Related]
5. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy: regulation by prolactin and placental lactogens.
Telleria CM; Zhong L; Deb S; Srivastava RK; Park KS; Sugino N; Park-Sarge OK; Gibori G
Endocrinology; 1998 May; 139(5):2432-42. PubMed ID: 9564855
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas.
Friend KE; Chiou YK; Lopes MB; Laws ER; Hughes KM; Shupnik MA
J Clin Endocrinol Metab; 1994 Jun; 78(6):1497-504. PubMed ID: 7515390
[TBL] [Abstract][Full Text] [Related]
9. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.
Petersen DN; Tkalcevic GT; Koza-Taylor PH; Turi TG; Brown TA
Endocrinology; 1998 Mar; 139(3):1082-92. PubMed ID: 9492041
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
11. 4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta.
Quaedackers ME; Van Den Brink CE; Wissink S; Schreurs RH; Gustafsson JA; Van Der Saag PT; Van Der Burg BB
Endocrinology; 2001 Mar; 142(3):1156-66. PubMed ID: 11181531
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
Huo B; Dossing DA; Dimuzio MT
J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation and action of estrogen receptors alpha and beta in GH3 cells.
Mitchner NA; Garlick C; Steinmetz RW; Ben-Jonathan N
Endocrinology; 1999 Jun; 140(6):2651-8. PubMed ID: 10342855
[TBL] [Abstract][Full Text] [Related]
14. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors.
Dahia PL; Honegger J; Reincke M; Jacobs RA; Mirtella A; Fahlbusch R; Besser GM; Chew SL; Grossman AB
J Clin Endocrinol Metab; 1997 Apr; 82(4):1088-93. PubMed ID: 9100578
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
16. Differential subcellular distribution and transcriptional activity of sigmaE3, sigmaE4, and sigmaE3-4 isoforms of the rat estrogen receptor-alpha.
Pasqualini C; Guivarc'h D; Barnier JV; Guibert B; Vincent JD; Vernier P
Mol Endocrinol; 2001 Jun; 15(6):894-908. PubMed ID: 11376109
[TBL] [Abstract][Full Text] [Related]
17. The estrogen receptor alpha sigma3 mRNA splicing variant is differentially regulated by estrogen and progesterone in the rat uterus.
Varayoud J; Ramos JG; Monje L; Bosquiazzo V; Muñoz-de-Toro M; Luque EH
J Endocrinol; 2005 Jul; 186(1):51-60. PubMed ID: 16002535
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta mRNA expression in normal and adenomatous pituitaries.
Gittoes NJ; McCabe CJ; Sheppard MC; Franklyn JA
Pituitary; 1999; 1(2):99-104. PubMed ID: 11081187
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.
Zafar M; Ezzat S; Ramyar L; Pan N; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610
[TBL] [Abstract][Full Text] [Related]
20. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.
Erenburg I; Schachter B; Mira y Lopez R; Ossowski L
Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
